Anna Chérouvrier Hansson
Chief Commercial Officer since 2017.
Anna has extensive experience from marketing, sales and business development from Camurus, Novo Nordisk, Gambro and DuPont among others. In addition, Anna has been a partner at Zitha Consulting, focusing on commercialisation strategy in the pharmaceutical industry and head of Life Science investments at Invest in Skåne.
Education: MSc in European Business Administration and Business Law, BSc in Business Administration.
Shareholding: 16 760 shares (privately and through related parties) and 10 000 warrants (entitles 10 000 new shares).*